Overview

Efficacy of Ticagrelor Plus Aspirin in Minor Non-cardioembolic Ischemic Stroke

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled, active comparator arm, outcome assessor blind, parallel group design on 90 patient with diagnosis of ischemic stroke admitted in Bou-Ali Sina Hospital, Sari,Iran.The aim of study is assess the efficacy of ticagrelor plus aspirin in reduce of minor non-cardioembolic ischemic stroke or high risk TIA recurrence during first 3 months.
Phase:
Phase 3
Details
Lead Sponsor:
Mazandaran University of Medical Sciences
Treatments:
Clopidogrel
Ticagrelor